2023年4月7日 · Rivaroxaban is used to treat or prevent blood clots (venous thromboembolism, or VTE). Blood clots can occur in the legs (deep vein thrombosis, DVT) or the lungs (pulmonary embolism, PE).

Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [10] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 10 ]

2025年3月1日 · Rivaroxaban is a factor Xa inhibitor, an anticoagulant. It works by decreasing the clotting ability of the blood and helps prevent harmful clots from forming in the blood vessels. This medicine is available only with your doctor's prescription.

Medscape - DVT/PE prevention and treatment dosing for Xarelto (rivaroxaban), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and...

2024年5月29日 · Find patient medical information for Xarelto (rivaroxaban) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

2021年4月27日 · Rivaroxaban is a prescription medication that's used to treat and prevent blood clots. It’s also used to reduce the risk of stroke and other heart problems in certain people.

2024年11月19日 · Learn about the side effects of rivaroxaban, from common to rare, for consumers and healthcare professionals.

2023年4月17日 · Rivaroxaban was the first orally dosed, direct Factor Xa inhibitor, a small-molecule oxazolidinone derivative. It binds directly and reversibly to Factor Xa via the S1 and S4 pockets. Rivaroxaban competitively inhibits Factor Xa, demonstrating more than 10,000-fold selectivity for Factor Xa than other related serine proteases.

WHAT IS XARELTO (rivaroxaban)? XARELTO is a prescription medicine used to: reduce the risk of stroke and blood clots in adults who have a medical condition called atrial fibrillation that is …

Rivaroxaban is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults. Rivaroxaban is also used to prevent DVT and PE from happening again after initial treatment is completed in adults.